EUVIMEDEUVIMED entdecken
Crossref

N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression

Liping Lai, Xiaoxiao Feng, Yiting Zheng, Shanrong Shu

Oncology Letters · 03.11.2026 · 33 (1) · 1-10

DOI: 10.3892/ol.2026.15937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 03.11.2026. Verfasst von Liping Lai und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lai, L., Feng, X., Zheng, Y., & Shu, S. (2026). N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression. Oncology Letters, 33(1), 1-10. https://doi.org/10.3892/ol.2026.15937

Vancouver

Lai L, Feng X, Zheng Y, Shu S. N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression. Oncology Letters. 2026;33(1):1-10. doi:10.3892/ol.2026.15937

BibTeX
@article{Lai2026,
  author = {Lai, Liping and Feng, Xiaoxiao and Zheng, Yiting and Shu, Shanrong},
  title = {N 6 ‑methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ‑EPB41L2 expression},
  journal = {Oncology Letters},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {1--10},
  doi = {10.3892/ol.2026.15937}
}
Kostenlos starten →